CIA: Director 'stands by' Russian interference assessment

New Post Public Reply Private Reply Replies (2) Message Board
john1234 PoemStone #27140
232
CIA: Director 'stands by' Russian interference assessment


The CIA on Saturday said its director, Mike Pompeo, "stands by" the intelligence community's declassified report that concluded Russia ran an influence campaign aimed at helping President Trump win the White House in 2016.

"The director stands by and has always stood by the January 2017 intelligence community assessment entitled: 'Assessing Russian Activities and Intentions in Recent U.S. Elections.' The intelligence assessment with regard to Russian election meddling has not changed," a spokesperson for the agency said in a statement.


The statement follows President Trump's comments about Russian President Vladimir Putin's repeated denials that Moscow was involved in election interference, as well as a discussion between the two world leaders.

The CIA did not comment on Trump's meeting in Vietnam with Putin.

"He said he didn't meddle. He said he didn't meddle. I asked him again. You can only ask so many times," Trump told reporters Saturday.

"But I just asked him again, and he said he absolutely did not meddle in our election," he continued. "He did not do what they're saying he did."

Trump and Putin spoke this weekend in Vietnam during the Asia-Pacific Economic Cooperation summit.

While Trump did not say whether or not he believed Putin's denial, he did mock those who led the intelligence agencies when the report was released in January.

"I think that he is very, very strong in the fact that he didn't do it," Trump said when asked if he believed Putin.

Trump has long argued that the investigation into Russia's election meddling and any potential ties between his campaign staff members and the Kremlin is politically motivated and an excuse for Hillary Clinton's loss last year.

https://www.msn.com/en-us/news/politics/cia-d...li=BBnb7Kz
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Workhorse Group Battles Nasdaq Compliance Amid Financial Woes

Updated Category News Views 87

Workhorse Group Faces Nasdaq Compliance Challenges Workhorse Group Inc (NASDAQ: WKHS), a manufacturer in the electric vehicle sector, has recently been issued a notice by the Nasdaq Stock Market regarding its non-compliance with the minimum bid price requirement. The pressing issue arises from the company's common stock trading below the $1.00 mark for a continuous period...

Continue Reading
Investors Have a Deadline to Join NET Power Class Action

Updated Category News Views 293

Investors Have a Deadline to Join NET Power Class Action In a significant turn of events, Kahn Swick & Foti, LLC advises investors who’ve incurred losses exceeding $100,000 in NET Power Inc. to take action. If you are among those affected, the time is critical. You have until June 17, 2025 to file your lead plaintiff application in this securities class action lawsuit...

Continue Reading
New Developments in Borregaard ASA's Share Transactions

Updated Category News Views 152

Insight into Recent Share Purchases at Borregaard ASA Recently, significant transactions have emerged within Borregaard ASA that are noteworthy for investors and stakeholders alike. Tove Andersen, a dedicated member of the board, made headlines by acquiring 2,000 shares at a price of NOK 187.92 each. This purchase marks a decisive move, increasing her total holdings to...

Continue Reading
Guaranteed Roof Enhances Commercial Roofing Options in NC

Updated Category News Views 136

Guaranteed Roof Enhances Commercial Roofing Options in North Carolina Guaranteed Roof, recognized for its expertise in roof rejuvenation and replacement services, is excited to announce a major enhancement to its commercial division. This initiative strongly emphasizes the utilization of FAR Coatings, a cutting-edge solution for flat and low-slope roofs. By leveraging...

Continue Reading
Key Details for Sage Therapeutics, Inc. Investors Ahead of Deadline

Updated Category News Views 38

Understanding the Class Action for Sage Therapeutics, Inc. As a diligent investor, knowing your rights is crucial, especially when involved with companies like Sage Therapeutics, Inc. (NASDAQ: SAGE). If you purchased securities between specific dates, it’s essential to pay attention to upcoming deadlines. The Importance of the Deadline The Rosen Law Firm, a leading...

Continue Reading